Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1

Journal of Molecular Biology

Volumn 415, Issue 2, 2012, Pages 288-306

  Zebisch, Matthias ^a   Krauss, Michel ^a   Schäfer, Petra ^a   Sträter, Norbert ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

CD39; ellipsoidal truncation; kinetic ITC; polyoxometallate; purinergic signaling

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; APYRASE; CD39 ANTIGEN; HYDROLASE; MOLYBDENUM; NUCLEIC ACID BASE; NUCLEOSIDE TRIPHOSPHATE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; NUCLEOTIDASE; NUCLEOTIDE; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ARTICLE; BLOOD FLOW; CATALYSIS; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME STRUCTURE; HYDROLYSIS; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; RAT; REGULATORY MECHANISM; THROMBOCYTE AGGREGATION;

BACTERIA (MICROORGANISMS); EUKARYOTA; RATTUS;

EID: 84855762914     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.10.050     Document Type: Article

References (90)

1. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade Biochim. Biophys. Acta 1783 2008 673 694
2. Robson S.C., Sévigny J., and Zimmerman H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance Purinergic Signal. 2 2006 409 430
3. Kaczmarek E., Koziak K., Sévigny J., Siegel J.B., Anrather J., and Beaudoin A.R. Identification and characterization of CD39/vascular ATP diphosphohydrolase J. Biol. Chem 271 1996 33116 33122 (Pubitemid 27008752)
4. Enjyoji K., Sévigny J., Lin Y., Frenette P.S., Christie P.D., and Esch J.S. II Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation Nat. Med. 5 1999 1010 1017 (Pubitemid 29439571)
5. Atkinson B., Dwyer K., Enjyoji K., and Robson S.C. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets Blood Cells Mol. Dis. 36 2006 217 222
6. Mandapathil M., Lang S., Gorelik E., and Whiteside T.L. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression J. Immunol. Methods 346 2009 55 63
7. Laliberte J.F., and Beaudoin A.R. Sequential hydrolysis of the γ- and β-phosphate groups of ATP by the ATP diphosphohydrolase from pig pancreas Biochim. Biophys. Acta 742 1983 9 15
8. Heine P., Braun N., Heilbronn A., and Zimmermann H. Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells Eur. J. Biochem 262 1999 102 107 (Pubitemid 29242615)
9. Kukulski F., Lévesque S.A., Lavoie É.G., Lecka J., Bigonnesse F., and Knowles A.F. Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8 Purinergic Signal. 1 2005 193 204 (Pubitemid 40475234)
10. Sévigny J., Sundberg C., Braun N., Guckelberger O., Csizmadia E., and Qawi I. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood 99 2002 2801 2809 (Pubitemid 34525368)
11. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Pinsky D.J., Sesti C., and Levi R. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1) J. Thromb. Haemost. 1 2003 2497 2509
12. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Pinsky D.J., Sesti C., and Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases J. Pharmacol. Exp. Ther. 305 2003 9 16 (Pubitemid 36373830)
13. Kauffenstein G., Drouin A., Thorin-Trescases N., Bachelard H., Robaye B., and D'Orléans-Juste P. NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse Cardiovasc. Res. 85 2010 204 213
14. Friedman D.J., Künzli B.M., Rahim Y.I., Sévigny J., Berberat P.O., and Enjyoji K. CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease Proc. Natl Acad. Sci. USA 106 2009 16788 16793
15. Hyman M.C., Petrovic-Djergovic D., Visovatti S.H., Liao H., Yanamadala S., and Bouïs D. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39 J. Clin. Invest. 119 2009 1136 1149
16. Schetinger M.R., Morsch V.M., Bonan C.D., and Wyse A.T. NTPDase and 5′-nucleotidase activities in physiological and disease conditions: new perspectives for human health Biofactors 31 2007 77 98
17. + Treg cells: hydrolysis of extracellular ATP and immune suppression Blood 110 2007 1225 1232 (Pubitemid 47281420)
18. Dwyer K., Deaglio S., Gao W., Friedman D., Strom T., and Robson S. CD39 and control of cellular immune responses Purinergic Signal. 3 2007 171 180
19. Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., and Erat A. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression J. Exp. Med. 204 2007 1257 1265 (Pubitemid 46919862)
20. Nikolova M., Carriere M., Jenabian M.A., Limou S., Younas M., and Kok A. CD39/adenosine pathway is involved in AIDS progression PLoS Pathog. 7 2011 e1002110
21. Barat C., Martin G., Beaudoin A.R., Sévigny J., and Tremblay M.J. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active J. Mol. Biol. 371 2007 269 282 (Pubitemid 47030458)
22. Leal D.B., Streher C.A., Bertoncheli C.M., Carli L.F., Leal C.A., and da Silva J.E. HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes Biochim. Biophys. Acta 1746 2005 129 134 (Pubitemid 41774287)
23. Goepfert C., Sundberg C., Sévigny J., Enjyoji K., Hoshi T., Csizmadia E., and Robson S. Disordered cellular migration and angiogenesis in cd39-null mice Circulation 104 2001 3109 3115 (Pubitemid 34014066)
24. Buffon A., Wink M.R., Ribeiro B.V., Casali E.A., Libermann T.A., and Zerbini L.F. NTPDase and 5′ ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the Walker 256 tumor Biochim. Biophys. Acta 1770 2007 1259 1265 (Pubitemid 47007733)
25. Buffon A., Ribeiro V.B., Wink M.R., Casali E.A., and Sarkis J.J. Nucleotide metabolizing ecto-enzymes in Walker 256 tumor cells: molecular identification, kinetic characterization and biochemical properties Life Sci. 80 2007 950 958 (Pubitemid 46188644)
26. Jackson S.W., Hoshi T., Wu Y., Sun X., Enjyoji K., and Cszimadia E. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice Am. J. Pathol. 171 2007 1395 1404 (Pubitemid 47582911)
27. Dzhandzhugazyan K.N., Kirkin A.F., thor Straten P., and Zeuthen J. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas FEBS Lett. 430 1998 227 230 (Pubitemid 28337918)
28. Künzli B.M., Berberat P.O., Giese T., Csizmadia E., Kaczmarek E., and Baker C. Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease Am. J. Physiol. Gastrointest. Liver Physiol. 292 2007 G223 G230
29. Feng L., Sun X., Csizmadia E., Han L., Bian S., and Murakami T. Vascular CD39/ENTPD1 directly promotes tumor cell growth by Scavenging extracellular adenosine triphosphate Neoplasia 13 2011 206 216
30. Gendron F.P., Benrezzak O., Krugh B.W., Kong Q., Weisman G.A., and Beaudoin A.R. Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition Curr. Drug Targets 3 2002 229 245 (Pubitemid 34555496)
31. Windsor J.B., Thomas C., Hurley L., Roux S.J., and Lloyd A.M. Automated colorimetric screen for apyrase inhibitors Biotechniques 33 2002 1024 1030 (Pubitemid 35285535)
32. Müller C.E., Iqbal J., Baqi Y., Zimmermann H., Rollich A., and Stephan H. Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors Bioorg. Med. Chem. Lett. 16 2006 5943 5947 (Pubitemid 44667816)
33. Mandapathil M., Szczepanski M.J., Szajnik M., Ren J., Lenzner D.E., and Jackson E.K. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer Clin. Cancer Res. 15 2009 6348 6357
34. Baqi Y., Weyler S., Iqbal J., Zimmermann H., and Muller C.E. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases) Purinergic Signal. 5 2009 91 106
35. Brunschweiger A., Iqbal J., Umbach F., Scheiff A.B., Munkonda M.N., and Sévigny J. Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5′- carboxamide J. Med. Chem. 51 2008 4518 4528
36. Gendron F.P., Halbfinger E., Fischer B., Duval M., D'Orleans-Juste P., and Beaudoin A.R. Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations J. Med. Chem. 43 2000 2239 2247 (Pubitemid 30354548)
37. Furukoji E., Tanaka N., Yamashita A., Matsumoto M., Fujimura Y., and Yamamoto R. Ecto-nucleoside triphosphate diphosphohydrolase inhibits ATP- and ADP-induced vasoconstriction Thromb. Res. 121 2008 583 585 (Pubitemid 351174270)
38. 1 receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window Trends Cardiovasc. Med. 19 2009 1 5
39. Pinsky D.J., Broekman M.J., Peschon J.J., Stocking K.L., Fujita T., and Ramasamy R. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain J. Clin. Invest. 109 2002 1031 1040 (Pubitemid 34408578)
40. Marcus A.J., Broekman M.J., Drosopoulos J.H., Olson K.E., Islam N., Pinsky D.J., and Levi R. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection Semin. Thromb. Hemost. 31 2005 234 246 (Pubitemid 40605197)
41. Koziak K., Bojakowska M., Robson S.C., Bojakowski K., Soin J., and Csizmadia E. Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty J. Thromb. Haemost. 6 2008 1191 1197 (Pubitemid 351859130)
42. Gayle R.B. III, C.R. Maliszewski, S.D. Gimpel, M.A. Schoenborn, R.G. Caspary, and C. Richards Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39 J. Clin. Invest. 101 1998 1851 1859 (Pubitemid 28226103)
43. Dwyer K.M., Robson S.C., Nandurkar H.H., Campbell D.J., Gock H., and Murray-Segal L.J. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation J. Clin. Invest. 113 2004 1440 1446 (Pubitemid 39071699)
44. Buergler J.M., Maliszewski C.R., Broekman M.J., Kaluza G.L., Schulz D.G., and Marcus A.J. Effects of SolCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model J. Thromb. Thrombolysis 19 2005 115 122 (Pubitemid 41131266)
45. Zhong X., Buddha M., Guidotti G., Kriz R., Somers W., and Mosyak L. Expression, purification and crystallization of the ecto-enzymatic domain of rat E-NTPDase1 CD39 Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun 64 2008 1063 1065
46. Zebisch M., and Sträter N. Characterization of rat NTPDase1, -2, and -3 ectodomains refolded from bacterial inclusion bodies Biochemistry 46 2007 11945 11956 (Pubitemid 47623763)
47. Zebisch M., and Sträter N. Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling Proc. Natl Acad. Sci. USA 105 2008 6882 6887 (Pubitemid 351754499)
48. Todd M.J., and Gomez J. Enzyme kinetics determined using calorimetry: a general assay for enzyme activity? Anal. Biochem. 296 2001 179 187 (Pubitemid 32868499)
49. Quesada-Soriano I., Casas-Solvas J.M., Recio E., Ruiz-Pérez L.M., Vargas-Berenguel A., González-Pacanowska D., and García-Fuentes L. Kinetic properties and specificity of trimeric Plasmodium falciparum and human dUTPases Biochimie 92 2010 178 186
50. Murphy-Piedmonte D.M., Crawford P.A., and Kirley T.L. Bacterial expression, folding, purification and characterization of soluble NTPDase5 (CD39L4) ecto-nucleotidase Biochim. Biophys. Acta 1747 2005 251 259 (Pubitemid 40215166)
51. Weiss M.S. Global indicators of X-ray data quality J. Appl. Crystallogr. 34 2001 130 135 (Pubitemid 32290301)
52. Wang T.F., Ou Y., and Guidotti G. The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure J. Biol. Chem. 273 1998 24814 24821 (Pubitemid 28454986)
53. Heine P., Braun N., Sévigny J., Robson S.C., Servos J., and Zimmermann H. The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2 Eur. J. Biochem. 268 2001 364 373 (Pubitemid 32862667)
54. Munkonda M.N., Pelletier J., Ivanenkov V.V., Fausther M., Tremblay A., and Künzli B. Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3: partial characterization of the inhibitory epitope and potential applications FEBS J. 276 2009 479 496
55. Ivanenkov V.V., Crawford P.A., Toyama A., Sevigny J., and Kirley T.L. Epitope mapping in cell surface proteins by site-directed masking: defining the structural elements of NTPDase3 inhibition by a monoclonal antibody Protein Eng. Des. Sel. 23 2010 579 588
56. Bork P., Sander C., and Valencia A. An ATPase domain common to prokaryotic cell cycle proteins, sugar kinases, actin, and hsp70 heat shock proteins Proc. Natl Acad. Sci. USA 89 1992 7290 7294
57. Schuler H. ATPase activity and conformational changes in the regulation of actin Biochim. Biophys. Acta 1549 2001 137 147 (Pubitemid 33022682)
58. Grinthal A., and Guidotti G. CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why? Purinergic Signal. 2 2006 391 398
59. Chiang W.C., and Knowles A.F. Inhibition of human NTPDase 2 by modification of an intramembrane cysteine by p-chloromercuriphenylsulfonate and oxidative cross-linking of the transmembrane domains Biochemistry 47 2008 8775 8785
60. Chiang W.C., and Knowles A.F. Transmembrane domain interactions affect the stability of the extracellular domain of the human NTPDase 2 Arch. Biochem. Biophys. 472 2008 89 99
61. Knowles A.F. The GDA1-CD39 superfamily: NTPDases with diverse functions Purinergic. Signal. 7 2011 21 45
62. Li C.S., Lee Y., and Knowles A.F. The stability of chicken nucleoside triphosphate diphosphohydrolase 8 requires both of its transmembrane domains Biochemistry 49 2010 134 146
63. Grinthal A., and Guidotti G. Dynamic motions of CD39 transmembrane domains regulate and are regulated by the enzymatic active site Biochemistry 43 2004 13849 13858 (Pubitemid 39431068)
64. Grinthal A., and Guidotti G. Bilayer mechanical properties regulate the transmembrane helix mobility and enzymatic state of CD39 Biochemistry 46 2007 279 290 (Pubitemid 46067757)
65. Gaddie K.J., and Kirley T.L. Conserved polar residues stabilize transmembrane domains and promote oligomerization in human nucleoside triphosphate diphosphohydrolase 3 Biochemistry 48 2009 9437 9447
66. Gaddie K.J., and Kirley T.L. Proline residues link the active site to transmembrane domain movements in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3) Purinergic Signal. 6 2010 327 337
67. Mukasa T., Lee Y., and Knowles A.F. Either the carboxyl- or the amino-terminal region of the human ecto-ATPase (E-NTPDase 2) confers detergent and temperature sensitivity to the chicken ecto-ATP-diphosphohydrolase (E-NTPDase 8) Biochemistry 44 2005 11160 11170 (Pubitemid 41209052)
68. Hayward S., and Berendsen H.J. Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme Proteins 30 1998 144 154 (Pubitemid 28080149)
69. Hayward S. Structural principles governing domain motions in proteins Proteins 36 1999 425 435 (Pubitemid 29387741)
70. Vivian J.P., Riedmaier P., Ge H., Le N.J., Sansom F.M., and Wilce M.C. Crystal structure of a Legionella pneumophila ecto-triphosphate diphosphohydrolase, a structural and functional homolog of the eukaryotic NTPDases Structure 18 2010 228 238
71. Kristensen O., Laurberg M., Liljas A., Kastrup J.S., and Gajhede M. Structural characterization of the stringent response related exopolyphosphatase/guanosine pentaphosphate phosphohydrolase protein family Biochemistry 43 2004 8894 8900 (Pubitemid 38924424)
72. Kristensen O., Ross B., and Gajhede M. Structure of the PPX/GPPA phosphatase from Aquifex aeolicus in complex with the alarmone ppGpp J. Mol. Biol. 375 2008 1469 1476
73. Ivanenkov V.V., Meller J., and Kirley T.L. Characterization of disulfide bonds in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): implications for NTPDase structural modeling Biochemistry 44 2005 8998 9012 (Pubitemid 40943216)
74. Musi E., Islam N., and Drosopoulos J.H. Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants Arch. Biochem. Biophys. 461 2007 30 39 (Pubitemid 46627525)
75. Iqbal J., Vollmayer P., Braun N., Zimmermann H., and Müller C.E. A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction Purinergic Signal. 1 2005 349 358 (Pubitemid 43023768)
76. Mizoue L.S., and Tellinghuisen J. The role of backlash in the "first injection anomaly" in isothermal titration calorimetry Anal. Biochem. 326 2004 125 127 (Pubitemid 38177493)
77. Sansom F.M., Riedmaier P., Newton H.J., Dunstone M.A., Muller C.E., and Stephan H. Enzymatic properties of an ecto-nucleoside triphosphate diphosphohydrolase from Legionella pneumophila: substrate specificity and requirement for virulence J. Biol. Chem. 283 2008 12909 12918
78. Bianconi M.L. Calorimetry of enzyme-catalyzed reactions Biophys. Chem. 126 2007 59 64 (Pubitemid 46206055)
79. Freyer M.W., and Lewis E.A. Isothermal titration calorimetry: experimental design, data analysis, and probing macromolecule/ligand binding and kinetic interactions Methods Cell Biol. 84 2008 79 113
80. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants J. Appl. Crystallogr. 26 1993 795 800
81. Evans P. Scaling and assessment of data quality Acta Crystallogr., Sect. D: Biol. Crystallogr. 62 2006 72 82
82. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., and Read R.J. Phaser crystallographic software J. Appl. Crystallogr. 40 2007 658 674 (Pubitemid 47080256)
83. Vagin A., and Teplyakov A. MOLREP: an automated program for molecular replacement J. Appl. Crystallogr. 30 1997 1022 1025 (Pubitemid 127485985)
84. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr., Sect. D: Biol. Crystallogr. 53 1997 240 255 (Pubitemid 27235885)
85. Cowtan K. Error estimation and bias correction in phase-improvement calculations Acta Crystallogr., Sect. D: Biol. Crystallogr. 55 1999 1555 1567 (Pubitemid 29449865)
86. Cowtan K. The Buccaneer software for automated model building. 1. Tracing protein chains Acta Crystallogr., Sect. D: Biol. Crystallogr. 62 2006 1002 1011 (Pubitemid 44337374)
87. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132 (Pubitemid 41742764)
88. Gili P., Lorenzo-Luis P.A., Mederos A., Arrieta J.M., Germain G., Castiñeiras A., and Carballo R. Crystal structures of two new heptamolybdates and of a pyrazole incorporating a γ-octamolybdate anion Inorg. Chim. Acta 295 1999 106 114
89. 2O Z. fur Kristallogr. 223 2008 45 47
90. Krissinel E., and Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions Acta Crystallogr., Sect. D. Biol. Crystallogr. 60 2004 2256 2268 (Pubitemid 41742778)